Ouedraogo G, Alépée N, Tan B, Roper C S
L'Oréal R&I, 41 Rue Martre, 92117, Clichy, France.
L'Oréal R&I, 41 Rue Martre, 92117, Clichy, France.
Regul Toxicol Pharmacol. 2025 Nov;162:105904. doi: 10.1016/j.yrtph.2025.105904. Epub 2025 Jul 8.
The transition from traditional animal testing to human-relevant New Approach Methods (NAMs) in regulatory toxicology faces a significant challenge: a lack of standardized validation and acceptance criteria. This review analyses the limitations of animal test reproducibility and highlights the growing body of evidence supporting the improved reliability and relevance of NAMs for predicting human toxicity. Successful case studies of NAMs implementation across diverse industries are examined and existing regulatory perspectives and initiatives are critically evaluated. This analysis reveals a pressing need for a unified, cross-industry approach to NAMs validation, grounded in measurable quality standards and standardisation. A framework is proposed based on clearly defined standards, standardized protocols, and transparent data sharing to accelerate the integration of NAMs into regulatory decision-making, ultimately benefiting human health, animal welfare, and scientific progress. All stakeholders are urged to actively participate in this initiative by contributing their expertise, sharing data and insights, and collaborating on the development and implementation of this crucial use of NAMs in regulatory toxicology.
在监管毒理学中,从传统动物试验向与人类相关的新方法(NAMs)转变面临重大挑战:缺乏标准化的验证和接受标准。本综述分析了动物试验可重复性的局限性,并强调了越来越多的证据支持NAMs在预测人类毒性方面具有更高的可靠性和相关性。考察了不同行业实施NAMs的成功案例研究,并对现有的监管观点和举措进行了批判性评估。该分析表明,迫切需要一种基于可衡量的质量标准和标准化的统一跨行业NAMs验证方法。基于明确的标准、标准化方案和透明的数据共享提出了一个框架,以加速将NAMs纳入监管决策,最终造福人类健康、动物福利和科学进步。敦促所有利益相关者通过贡献专业知识、分享数据和见解以及就监管毒理学中NAMs的这一关键用途的开发和实施开展合作,积极参与这一倡议。